These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9678437)

  • 1. Apoptosis of tubular epithelial cells in familial juvenile gouty nephropathy.
    Lhotta K; Gruber J; Sgonc R; Fend F; König P
    Nephron; 1998; 79(3):340-4. PubMed ID: 9678437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal handling of urate in a patient with familial juvenile gouty nephropathy.
    Hisatome I; Kosaka H; Ohtahara K; Tsuboi M; Manabe I; Ohtahara A; Sawaguchi M; Igawa O; Tanaka Y; Fujimoto Y; Yoshida A; Takeda A; Shigemasa C
    Intern Med; 1996 Jul; 35(7):564-8. PubMed ID: 8842764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Uricosuric agent].
    Ohno I
    Nihon Rinsho; 2008 Apr; 66(4):743-7. PubMed ID: 18409525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial hyperuricemic nephropathy.
    Reiter L; Brown MA; Edmonds J
    Am J Kidney Dis; 1995 Feb; 25(2):235-41. PubMed ID: 7847350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial nephropathy with hyperuricemia and gout.
    Leumann EP; Wegmann W
    Nephron; 1983; 34(1):51-7. PubMed ID: 6855996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient.
    Decaux G; Soupart A; Musch W; Hannotier P; Prospert F
    Clin Nephrol; 1998 Oct; 50(4):262-5. PubMed ID: 9799074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newly discovered familial juvenile gouty nephropathy in a Japanese family.
    Saeki A; Hosoya T; Okabe H; Saji M; Tabe A; Ichida K; Itoh K; Joh K; Sakai O
    Nephron; 1995; 70(3):359-66. PubMed ID: 7477627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of urate-lowering therapies on renal handling of uric acid.
    Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
    Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients.
    Reinders MK; van Roon EN; Houtman PM; Brouwers JR; Jansen TL
    Clin Rheumatol; 2007 Sep; 26(9):1459-65. PubMed ID: 17308859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperuricemia, gout and the kidney.
    Gibson T
    Curr Opin Rheumatol; 2012 Mar; 24(2):127-31. PubMed ID: 22157498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.
    Ahn SO; Ohtomo S; Kiyokawa J; Nakagawa T; Yamane M; Lee KJ; Kim KH; Kim BH; Tanaka J; Kawabe Y; Horiba N
    J Pharmacol Exp Ther; 2016 Apr; 357(1):157-66. PubMed ID: 26907620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urate transport via human PAH transporter hOAT1 and its gene structure.
    Ichida K; Hosoyamada M; Kimura H; Takeda M; Utsunomiya Y; Hosoya T; Endou H
    Kidney Int; 2003 Jan; 63(1):143-55. PubMed ID: 12472777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of renal uric acid excretion and gout.
    Taniguchi A; Kamatani N
    Curr Opin Rheumatol; 2008 Mar; 20(2):192-7. PubMed ID: 18349750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial urate nephropathy.
    Richmond JM; Kincaid-Smith P; Whitworth JA; Becker GJ
    Clin Nephrol; 1981 Oct; 16(4):163-8. PubMed ID: 7296976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal handling of uric acid in man.
    Levinson DJ; Decker DE; Sorensen LB
    Ann Clin Lab Sci; 1982; 12(1):73-7. PubMed ID: 7065639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Historical review of gout and hyperuricemia investigations].
    Nakamura T
    Nihon Rinsho; 2008 Apr; 66(4):624-35. PubMed ID: 18409506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK; van Roon EN; Jansen TL; Delsing J; Griep EN; Hoekstra M; van de Laar MA; Brouwers JR
    Ann Rheum Dis; 2009 Jan; 68(1):51-6. PubMed ID: 18250112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease in an adolescent with hyperuricemia: familial juvenile hyperuricemic nephropathy.
    Alaygut D; Torun-Bayram M; Soylu A; Kasap B; Türkmen M; Kavukçu S
    Turk J Pediatr; 2013; 55(6):637-40. PubMed ID: 24577984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial juvenile gouty nephropathy with renal urate hypoexcretion preceding renal disease.
    Moro F; Ogg CS; Simmonds HA; Cameron JS; Chantler C; McBride MB; Duley JA; Davies PM
    Clin Nephrol; 1991 Jun; 35(6):263-9. PubMed ID: 1873940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.